CNPR ACTUAL EXAM ALL QUESTIONS
AND WELL ELABORATED ANSWERS
TOP RATED VERSION FOR ALREADY A+
GRADED HIGHLY RECOMMENDED
|NEW AND REVISED
1.EHowEareEdrugsEsortedEintoEtherapeuticEgroupsEandEclasses?E-
ECORRECTEANSWERfirstEbyEtheEconditionsEthatEtheyEareEusedEtoEtreat.EandEthenEbyEtheirEmechanis
msEofEaction
2.EBoneEmarrowEtransplants.E-
ECORRECTEANSWERareEaEtypeEofEstemEcellEtherapy.EunlessEpatient'sEownEcellsEareEreinjected.
3.EWhatEdoesEAMAEstandEfor?E-ECORRECTEANSWERAmericanEMedicalEAssociation
4.EWhatEsectionEofEaEdrug'sEpackageEinsertEdescribesEsituationsEinEwhichEtheEdrugEshouldEnotEbeEu
sedEbecauseEtheErisksEoutweighEtheEtherapeuticEbenefits?E-ECORRECTEANSWERcontraindications
5EWhatEisEtertiaryEcare?E-
ECORRECTEANSWERhighlyEspecializedEmedicalEandEsurgicalEcareEprovidedEbyEaElargeEmedicalEcente
rEforEunusualEorEcomplexEmedicalEproblems
6.EWhichEofEtheEfollowingEisENOTEoneEofEtheEstagesEinEtheEclassicEapproachEtoEbrandEdevelopmentE
strategyEcoveredEinEyourEmanual?E-ECORRECTEANSWERbrandEquality
7EWhatEareEvasodilatorsEusedEtoEdo?E-
ECORRECTEANSWERdecreaseEvascularEresistanceEandEincreaseEbloodEflow
,8.EWhatEisEtheEnameEofEtheEconditionEthatEoccursEafterEaEspecificEdoseEofEaEdrugEisEgivenEatEsuchEre
gularEintervalsEthatEabsorptionEandEeliminationE(andEthereforeEdrugEplasmaEconcentration)EhaveEb
ecomeEfairlyEconstant?E-ECORRECTEANSWERSteadyEState
9.EWhichEstatementEisETRUEEaboutEocularEadministration?E-
ECORRECTEANSWEROcularEadministrationEisEusedEprimarilyEtoEtreatEtheEeye.
10.EWhichEentitiesEinvest'sEtheEmostEmoneyEinEpharmaceuticalER&D?E-
ECORRECTEANSWERU.S.EpharmaceuticalEcompanies
11.EHowEareEmostEdrugsEexcreted?E-ECORRECTEANSWERviaEtheEkidneys
12.EOverEtheElastEfewEdecades,EwhatEhasEhappenedEtoElegalElimitationsEonEsales'ErepsEdiscussionsEa
boutEoffElabelEuses?E-ECORRECTEANSWERLimitationsEhaveEdecreased.
14.EWhatEdoesEitEmeanEifEtwoEdrugsEareEatEparity?E-
ECORRECTEANSWERBothEdrugsEareEessentiallyEinEaEneutralEposition.
15EWhoEisEmostElikelyEtoEbenefitEfromEelectronicEsamplingEprograms?E-
ECORRECTEANSWEREveryoneEwouldEbenefitEequallyEfromEelectronicEsamplingEprograms
16.EWhenEreferringEtoEmedicationEdosage,EwhichEabbreviationEmeansE"one-half'E-
ECORRECTEANSWERSS
17EWhatEisEanEinternist?E-ECORRECTEANSWERaEphysicianEwhoEpracticesEinternalEmedicine
18.EWhichEofEtheEfollowingEisEaEtypeEofEwhiteEbloodEcell?E-ECORRECTEANSWERLymphocytes
, 19.EWhyEareEnoviceEsalesErepresentativesEoftenEplacedEinEchargeEofEnegotiatingEMCOEformularies?
E-ECORRECTEANSWERTheyEareEnot.EThisEjobEisEusuallyEreservedEforEmoreEexperiencedEreps.
20.EWhatEdistinguishesEpharmacodynamicsEfromEpharmacokinetics?E-
ECORRECTEANSWERPharmacodynamicsEstudiesEtheEhowEtheEbodyEaffectsEdrugs.
21EWhatEproportionEofEtheEdrugsEtestedEonEhumanEsubjectsEareEeventuallyEapprovedEbyEtheEFDA?E
-ECORRECTEANSWERaboutE70%
22.EAccordingEtoEaEstudyEdiscussedEinEyourEmanual,EhowEdoEmostEphysiciansEpreferEtoEreceiveEthei
rEdrugEsamples?E-ECORRECTEANSWERdirectlyEfromEsalesErepresentatives
23.EWhichEofEtheEfollowingEisEanEexampleEofEaEcentralEvalue?E-
ECORRECTEANSWERIEbuyEAdvilEtoEshowEthatEI'mEaEmodernEconsumer.
24.EWhichEofEtheEfollowingEspecialtiesElikelyEhasEtheEMOSTEemergencyEcalls?E-
ECORRECTEANSWERcardiologist
25.EWhatEaffectsEtheErateEofEactiveEtransport?E-
ECORRECTEANSWERneitherEtheEavailabilityEofEcarriersEnorEtheEavailabilityEofEenergy
26.EOverEtheElastEfewEdecades,EwhatEhasEhappenedEtoEtheEFDAEapprovalEtimeEforEnewEdrugs?E-
ECORRECTEANSWERItEhasEbeenEshortenedEtoEreduceEtheEcostEofEnewEdrugEdevelopment.
27.EWhichEofEtheEfollowingEwouldENOTEhelpEimproveEcompliance?E-
ECORRECTEANSWERpharmacistsEunderstandingEhowEgenericsEdifferEfromEbrandEnameEdrugs
28.EWhichEentityEchoosesEaEdrug'sEtradeEname?E-ECORRECTEANSWERtheEFDA
AND WELL ELABORATED ANSWERS
TOP RATED VERSION FOR ALREADY A+
GRADED HIGHLY RECOMMENDED
|NEW AND REVISED
1.EHowEareEdrugsEsortedEintoEtherapeuticEgroupsEandEclasses?E-
ECORRECTEANSWERfirstEbyEtheEconditionsEthatEtheyEareEusedEtoEtreat.EandEthenEbyEtheirEmechanis
msEofEaction
2.EBoneEmarrowEtransplants.E-
ECORRECTEANSWERareEaEtypeEofEstemEcellEtherapy.EunlessEpatient'sEownEcellsEareEreinjected.
3.EWhatEdoesEAMAEstandEfor?E-ECORRECTEANSWERAmericanEMedicalEAssociation
4.EWhatEsectionEofEaEdrug'sEpackageEinsertEdescribesEsituationsEinEwhichEtheEdrugEshouldEnotEbeEu
sedEbecauseEtheErisksEoutweighEtheEtherapeuticEbenefits?E-ECORRECTEANSWERcontraindications
5EWhatEisEtertiaryEcare?E-
ECORRECTEANSWERhighlyEspecializedEmedicalEandEsurgicalEcareEprovidedEbyEaElargeEmedicalEcente
rEforEunusualEorEcomplexEmedicalEproblems
6.EWhichEofEtheEfollowingEisENOTEoneEofEtheEstagesEinEtheEclassicEapproachEtoEbrandEdevelopmentE
strategyEcoveredEinEyourEmanual?E-ECORRECTEANSWERbrandEquality
7EWhatEareEvasodilatorsEusedEtoEdo?E-
ECORRECTEANSWERdecreaseEvascularEresistanceEandEincreaseEbloodEflow
,8.EWhatEisEtheEnameEofEtheEconditionEthatEoccursEafterEaEspecificEdoseEofEaEdrugEisEgivenEatEsuchEre
gularEintervalsEthatEabsorptionEandEeliminationE(andEthereforeEdrugEplasmaEconcentration)EhaveEb
ecomeEfairlyEconstant?E-ECORRECTEANSWERSteadyEState
9.EWhichEstatementEisETRUEEaboutEocularEadministration?E-
ECORRECTEANSWEROcularEadministrationEisEusedEprimarilyEtoEtreatEtheEeye.
10.EWhichEentitiesEinvest'sEtheEmostEmoneyEinEpharmaceuticalER&D?E-
ECORRECTEANSWERU.S.EpharmaceuticalEcompanies
11.EHowEareEmostEdrugsEexcreted?E-ECORRECTEANSWERviaEtheEkidneys
12.EOverEtheElastEfewEdecades,EwhatEhasEhappenedEtoElegalElimitationsEonEsales'ErepsEdiscussionsEa
boutEoffElabelEuses?E-ECORRECTEANSWERLimitationsEhaveEdecreased.
14.EWhatEdoesEitEmeanEifEtwoEdrugsEareEatEparity?E-
ECORRECTEANSWERBothEdrugsEareEessentiallyEinEaEneutralEposition.
15EWhoEisEmostElikelyEtoEbenefitEfromEelectronicEsamplingEprograms?E-
ECORRECTEANSWEREveryoneEwouldEbenefitEequallyEfromEelectronicEsamplingEprograms
16.EWhenEreferringEtoEmedicationEdosage,EwhichEabbreviationEmeansE"one-half'E-
ECORRECTEANSWERSS
17EWhatEisEanEinternist?E-ECORRECTEANSWERaEphysicianEwhoEpracticesEinternalEmedicine
18.EWhichEofEtheEfollowingEisEaEtypeEofEwhiteEbloodEcell?E-ECORRECTEANSWERLymphocytes
, 19.EWhyEareEnoviceEsalesErepresentativesEoftenEplacedEinEchargeEofEnegotiatingEMCOEformularies?
E-ECORRECTEANSWERTheyEareEnot.EThisEjobEisEusuallyEreservedEforEmoreEexperiencedEreps.
20.EWhatEdistinguishesEpharmacodynamicsEfromEpharmacokinetics?E-
ECORRECTEANSWERPharmacodynamicsEstudiesEtheEhowEtheEbodyEaffectsEdrugs.
21EWhatEproportionEofEtheEdrugsEtestedEonEhumanEsubjectsEareEeventuallyEapprovedEbyEtheEFDA?E
-ECORRECTEANSWERaboutE70%
22.EAccordingEtoEaEstudyEdiscussedEinEyourEmanual,EhowEdoEmostEphysiciansEpreferEtoEreceiveEthei
rEdrugEsamples?E-ECORRECTEANSWERdirectlyEfromEsalesErepresentatives
23.EWhichEofEtheEfollowingEisEanEexampleEofEaEcentralEvalue?E-
ECORRECTEANSWERIEbuyEAdvilEtoEshowEthatEI'mEaEmodernEconsumer.
24.EWhichEofEtheEfollowingEspecialtiesElikelyEhasEtheEMOSTEemergencyEcalls?E-
ECORRECTEANSWERcardiologist
25.EWhatEaffectsEtheErateEofEactiveEtransport?E-
ECORRECTEANSWERneitherEtheEavailabilityEofEcarriersEnorEtheEavailabilityEofEenergy
26.EOverEtheElastEfewEdecades,EwhatEhasEhappenedEtoEtheEFDAEapprovalEtimeEforEnewEdrugs?E-
ECORRECTEANSWERItEhasEbeenEshortenedEtoEreduceEtheEcostEofEnewEdrugEdevelopment.
27.EWhichEofEtheEfollowingEwouldENOTEhelpEimproveEcompliance?E-
ECORRECTEANSWERpharmacistsEunderstandingEhowEgenericsEdifferEfromEbrandEnameEdrugs
28.EWhichEentityEchoosesEaEdrug'sEtradeEname?E-ECORRECTEANSWERtheEFDA